Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Preventives for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.
Authors
Robert Brooks Hines
University of Central Florida College of Medicine, Orlando, FL
Robert Brooks Hines , Christopher Schoborg , Xiang Zhu , Elizabeth Elgin , Shunpu Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
DOI
10.1200/JCO.2022.40.4_suppl.083
Abstract #
83
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Duloxetine (DL) in treatment of oxaliplatin-induced peripheral neuropathy (PN).
First Author: Jeffrey Chi
Poster
2020 ASCO Virtual Scientific Program
A phase Ib adaptive study of dasatinib for the prevention of oxaliplatin-induced neuropathy in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy and bevacizumab.
First Author: Anne M. Noonan
Poster
2017 Gastrointestinal Cancers Symposium
A pilot-blinded randomized feasibility trial comparing an investigational hand therapy intervention (IHT) to a traditional occupational therapy (TOT) intervention to prevent chemotherapy induced peripheral neuropathy (CIPN) of the hands in patients (pts) receiving chemotherapy (CTX).
First Author: Gayle S. Jameson
Poster
2014 Palliative and Supportive Care in Oncology Symposium
Effect of duloxetine on chemotherapy-induced painful peripheral neuropathy.
First Author: Yasuo Hirayama